Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print)
2019 / N 3

Функция внешнего дыхания у больных системной склеродермией
А.В. Черняк

References

1. Caron M, Hoa S, Hudson M, Schwartzman K, Steele R. Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease. European Respiratory Review 2018 May;27(148). pii:170102.
2. Cottin V, Brown KK. Interstitial lung disease associated with systemic sclerosis (SSc-ILD). Respiratory Research 2019 Jan;20(1):13.
3. Ananyeva LP. Early systemic sclerosis – a current diagnostic algorithm (lecture). Rheumatology Science and Practice 2012;2(51):87-93 (In Russian).
4. Koroy PV. Systemic sclerosis. Vestnik Molodogo Uchenogo 2018;2(21):29-36 (In Russian).
5. Ahmed SS, Johnson SR, Meaney C, Chau C, Marras TK. Lung function and survival in systemic sclerosis interstitial lung disease. The Journal of Rheumatology 2014 Nov;41(11):2326-8.
6. Teplova LV, Ananyeva LP, Lesnyak VN, Starovoytova MN, Desinova OV, Nevskaya TA, Aleksandrova EN. Scleroderma systematica with interstitial lung lesion: comparative clinical features in patients without lung lesion. Rheumatology Science and Practice 2010;3:41-7 (In Russian).
7. Ananyeva LP. Diagnosis and treatment of interstitial lung damage in systemic scleroderma. Modern Rheumatology Journal 2018;12(2):12-21 (In Russian).
8. Ovsyannikova OB, Ananyeva LP, Lesnyak VN, Koneva OA, Starovoytova MN, Desinova OV. Changes of activity index and total severity index in patients with systemic sclerosis and interstitial lung disease over a 5-year follow-up period. Rheumatology Science and Practice 2016;54(3):312-7 (In Russian).
9. Hoffmann-Vold AM, Fretheim H, Halse AK, Seip M, Bitter H, Wallenius M, Garen T, Salberg A, Brunborg C, Midtvedt Ø, Lund MB, Aaløkken TM, Molberg Ø. Tracking impact of interstitial lung disease in systemic sclerosis in a complete nationwide cohort. American Journal of Respirology and Critical Care Medicine 2019 Nov;200(10):1258-66.
10. Nihtyanova S, Schreiber B, Ong V, Rosenberg D, Moinzadeh P, Coghlan J, Wells A, Denton C. Prediction of pulmonary complications and long-term survival in systemic sclerosis. Arthritis & Rheumatology (Hoboken, NJ.) 2014 Jun;66(6):1625-35.
11. Chuchalin AG, Aysanov ZR, Chikina SYu, Chernyak AV, Kalmanova EN. Federal guidelines of Russian Respiratory Society on spirometry. Russian Pulmonology 2014;6:11-24 (In Russian).
12. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force. Standardisation of spirometry. The European Respiratory Journal 2005 Aug;26(2):319-38.
13. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson D, MacIntyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G. Standardisation of the measurement of lung volumes. The European Respiratory Journal 2005 Sep;26(3):511-22.
14. MacIntyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, Gustafsson P, Hankinson J, Jensen R, McKay R, Miller MR, Navajas D, Pedersen OF, Pellegrino R, Wanger J. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. The European Respiratory Journal 2005 Oct;26(4):720-35.
15. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson DC, MacIntyre N, McKay R, Miller MR, Navajas D, Pedersen OF, Wanger J. Interpretative strategies for lung function tests. The European Respiratory Journal 2005 Nov;26(5):948-68.
16. Suliman YA, Dobrota R, Huscher D, Nguyen-Kim TD, Maurer B, Jordan S, Speich R, Frauenfelder T, Distler O. Brief report: pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease. Arthritis & Rheumatology (Hoboken, NJ.) 2015 Dec;67(12):3256-61.
17. Steen VD, Conte C, Owens GR, Medsger TA Jr. Severe restrictive lung disease in systemic sclerosis. Arthritis and Rheumatism 1994;37(9):1283-9.
18. Spagnolatti L, Zoia MC, Volpini E, Convertino G, Fulgoni P, Corsico A, Vitulo P, Cerveri I. Pulmonary function in patients with systemic sclerosis. Monaldi Archives for Chest Disease 1997 Feb;52(1):4-8.
19. Cappelli S, Bellando Randone S, Camiciottoli G, De Paulis A, Guiducci S, Matucci-Cerinic M. Interstitial lung disease in systemic sclerosis: where do we stand? The European Respiratory Review 2015 Sep;24(137):411-9.
20. Kostopoulos C, Rassidakis A, Sfikakis PP, Antoniades L, Mavrikakis M. Small airways dysfunction in systemic sclerosis. A controlled study. Chest 1992 Sep;102(3):875-81.
21. Schoenfeld SR, Castelino FV. Interstitial lung disease in scleroderma. Rheumatic Disease Clinics of North America 2015;41(2):237-48.
22. Bernstein EJ, Berrocal VJ, Steen VD, Shanmugam VK, Shah AA, Hinchcliff ME, Hant FN, Gordon JK, Frech TM, Domsic RT, Assassi S, Khanna D. The predictive value of pulmonary function tests to diagnose interstitial lung disease in adults with early diffuse cutaneous systemic sclerosis. Arthritis & Rheumatology (Hoboken, NJ.) 2015;67(Suppl 10):2268-9. Available from: https://acrabstracts.org/abstract/the-predictive-value-of-pulmonary-function-tests-to-diagnose-interstitial-lung-disease-in-adults-with-early-diffuse-cutaneous-systemic-sclerosis/ Accessed 2019 Dec 12.
23. Molberg Ø, Hoffmann-Vold AM. Interstitial lung disease in systemic sclerosis: progress in screening and early diagnosis. Current Opinion in Rheumatology 2016 Nov;28(6):613-8.
24. Ungerer RG, Tashkin DP, Furst D, Clements PJ, Gong H Jr, Bein M, Smith JW, Roberts N, Cabeen W. Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. The American Journal of Medicine 1983 Jul;75(1):65-74.
25. Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis and Rheumatism 2000 Nov;43(11):2437-44.
26. Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, Corte TJ, Sander CR, Ratoff J, Devaraj A, Bozovic G, Denton CP, Black CM, du Bois RM, Wells AU. Interstitial lung disease in systemic sclerosis: a simple staging system. American Journal of Respiratory and Critical Care Medicine 2008 Jun;177(11):1248-54.
27. Simeón CP, Armadans L, Fonollosa V, Solans R, Selva A, Villar M, Lima J, Vaqué J, Vilardell M. Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology (Oxford, England) 2003 Jan;42(1):71-5.
28. Morgan C, Knight C, Lunt M, Black C, Silman A. Predictors of end stage lung disease in a cohort of patients with scleroderma. Annals of Rheumatic Disease 2003 Feb;62(2):146-50.
29. Scussel-Lonzetti L, Joyal F, Raynauld JP, Roussin A, Rich E, Goulet JR, Raymond Y, Senécal JL. Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 2002 Mar;81(2):154-67.
30. Kafaja S, Clements PJ, Wilhalme H, Tseng CH, Furst DE, Kim GH, Goldin J, Volkmann ER, Roth MD, Tashkin DP, Khanna D. Reliability and minimal clinically important differences of forced vital capacity: results from the Scleroderma Lung Studies (SLS-I and SLS-II). American Journal of Respiratory and Critical Care Medicine 2018 Mar;197(5):644-52.
31. Khanna D, Nagaraja V, Tseng CH, Abtin F, Suh R, Kim G, Wells A, Furst DE, Clements PJ, Roth MD, Tashkin DP, Goldin J. Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials. Arthritis Research & Therapy 2015 Dec;17:372.
32. Bouros D, Wells AU, Nicholson AG, Colby TV, Polychronopoulos V, Pantelidis P, Haslam PL, Vassilakis DA, Black CM, du Bois RM. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. American Journal of Respiratory and Critical Care Medicine 2002 Jun;165(12):1581-6.
  

[ Содержание выпуска N 3 | Выпуски журнала | Список журналов ]